You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 3226 to 3250 of about 5895
Next 25
06/01/2009
Drug Made From Cottonseed May Slow Brain Cancer, Researchers Say
Most common brain cancer may originate in neural stem cells
Pfizer and Celldex Therapeutics Present Update on CDX-110 (PF-04948568) Phase 2 Brain Cancer Studies at 45th Annual ASCO Meeting
Added a few videos to the video library.. More will be added soon!
Updated survivor story Tom K
05/28/2009
Peregrine Pharmaceuticals Reports Progress in Cotara(R) Brain Cancer Clinical Program
Common Cancer Drug (Avastin) May Increase Risk of Deadly GI Perforations
05/27/2009
Amber Alert: Pennsylvania
05/26/2009
Call for support: Senator Kennedy`s Cancer Bill (S. 717 called 21st Century Cancer ALERT-
05/25/2009
Treating Untreatable Brain Tumors: FDA Approves New Laser Surgery
Brain Tumor Talk Radio
05/24/2009
IBTA E-News May 24 2009
05/22/2009
Retrospective analysis of outcomes among more than 1,000 patients with newly diagnosed anaplastic oligodendroglial tumors.
05/14/2009
Very late relapses in glioblastoma long-term survivors.
ASCO Abstracts now available online!
A phase II study of chemoradiation followed by adjuvant temozolomide and poly-ICLC in patients with newly diagnosed glioblastoma: 12- and 18-month survival data (NABTT 0501).
Bevacizumab in combination with radiotherapy plus concomitant and adjuvant temozolomide for newly diagnosed glioblastoma: Update progression-free survival, overall survival, and toxicity.
Epidermal growth factor receptor variant III (EGFRvIII) vaccine (CDX-110) in GBM.
Targeting brain tumor stem cells using a bispecific antibody directed against CD133+ and EGFRvIII+.
A phase I trial of tumor-associated antigen-pulsed dendritic cell immunotherapy for patients with brain stem glioma and glioblastoma.
A phase I trial of surgical resection with biodegradable carmustine (BCNU) wafer placement followed by vaccination with dendritic cells pulsed with tumor lysate for patients with malignant glioma.
A phase I evaluation of intravenous TM601 in recurrent glioblastoma: Use of perfusion MRI to monitor antiangiogenic effects.
The Role of Supplements (including Anti-Oxidants) in Cancer Treatment